Sotagliflozin Suppliers & Bulk Manufacturers

Sotagliflozin is used for improving blood glucose control in adults with type 1 diabetes (as an adjunct to insulin) and type 2 diabetes in some regions. It works by inhibiting both SGLT1 and SGLT2 transporters, reducing glucose absorption in the intestine and increasing glucose excretion through urine.

Sotagliflozin is made from the active ingredient sotagliflozin, a dual sodium–glucose cotransporter inhibitor that blocks SGLT1 in the gut and SGLT2 in the kidneys.

A well-known trade name for Sotagliflozin is Zynquista.

Zynquista was developed by Lexicon Pharmaceuticals in collaboration with Sanofi. In some regions, rights have been managed directly by Lexicon following partnership changes.

The generic name is sotagliflozin.

The brand name is Zynquista.

Sotagliflozin is manufactured in facilities authorized by Lexicon Pharmaceuticals and its regional partners, with production occurring in the United States and Europe depending on regulatory approvals and supply chains.